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Objective: This study sought to characterize the inflammatory infiltrate in ascending
thoracic aortic aneurysm in patients with Marfan syndrome, familial thoracic aortic
aneurysm, or nonfamilial thoracic aortic aneurysm.
Background: Thoracic aortic aneurysms are associated with a pathologic lesion
termed ‘‘medial degeneration,’’ which is described as a noninflammatory lesion. Tho-
racic aortic aneurysms are a complication of Marfan syndrome and can be inherited in
an autosomal dominant manner of familial thoracic aortic aneurysm.
Methods: Full aortic segments were collected from patients undergoing elective repair
withMarfan syndrome (n5 5), familial thoracic aortic aneurysm (n5 6), and thoracic
aortic aneurysms (n 5 9), along with control aortas (n 5 5). Immunohistochemistry
staining was performed using antibodies directed against markers of lymphocytes and
macrophages. Real-time polymerase chain reaction analysis was performed to quan-
tify the expression level of the T-cell receptor b-chain variable region gene.
Results: Immunohistochemistry of thoracic aortic aneurysm aortas demonstrated that
the media and adventitia from Marfan syndrome, familial thoracic aortic aneurysm,
and sporadic cases had increased numbers of T lymphocytes and macrophages
when compared with control aortas. The number of T cells and macrophages in the
aortic media of the aneurysm correlated inversely with the patient’s age at the time
of prophylactic surgical repair of the aorta. T-cell receptor profiling indicated a similar
clonal nature of the T cells in the aortic wall in a majority of aneurysms, whether the
patient had Marfan syndrome, familial thoracic aortic aneurysm, or sporadic disease.
Conclusion: These results indicate that the infiltration of inflammatory cells contrib-
utes to the pathogenesis of thoracic aortic aneurysms. Superantigen-driven stimula-
tion of T lymphocytes in the aortic tissues of patients with thoracic aortic
aneurysms may contribute to the initial immune response.
A
ortic aneurysms are classified in terms of their anatomic location and most
commonly occur in the infrarenal abdominal aorta (abdominal aortic aneu-
rysm [AAA]) and thoracic aorta (thoracic aortic aneurysm [TAA]). AAAs
primarily affect the elderly population and are characterized by atherosclerotic
changes with chronic inflammation of the aortic wall. In contrast, TAAs affect a youn-
ger population and the pathology present in the aortic wall in these patients is medial
degeneration (MD), described as a lesion characterized by the triad of loss of smooth
muscle cells, fragmented and diminished number of elastic fibers, and increased ac-
cumulation of proteoglycans.1 Individuals with TAAs are referred for prophylactic
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AAA 5 abdominal aortic aneurysm
FTAA 5 familial thoracic aortic aneurysm
ICAM 5 intercellular adhesion molecule
MD 5 medial degeneration
MFS 5 Marfan syndrome
PCR 5 polymerase chain reaction
TAA 5 thoracic aortic aneurysm
TCR BV 5 T-cell receptor b-chain variable region
TGFBR2 5 transforming growth factor b receptor type II
Th 5 T-helper
VCAM 5 vascular cell adhesion molecule
surgical repair of the ascending aorta when an aneurysm rea-
ches a diameter greater than 5 cm to prevent the life-threaten-
ing complications of aortic dissection or rupture.2
A number of genetic conditions can predispose individ-
uals to the formation of TAAs, most notably Marfan syn-
drome (MFS).3 MFS is a pleiotropic condition inherited in
an autosomal dominant manner that has associated skeletal
and ocular manifestations. A defective gene causing MFS,
FBN1, encodes for an extracellular matrix protein called ‘‘fi-
brillin-1,’’ a component of the elastic fiber system. The fibril-
lin-1 deficient mouse, an accepted model of MFS that
recapitulates the cardiovascular phenotype, shows MD in
the aortic wall that is associated with inflammatory infiltrates
before dilatation or dissection.4 A second gene for MFS was
recently identified as transforming growth factor b receptor
type II (TGFBR2).5
A genetic predisposition for TAA can also be inherited in
an autosomal dominant manner in the absence of any associ-
ated syndromic findings. Families with multiple affected
members typically demonstrate autosomal dominant inheri-
tance with decreased penetrance and variable expression, in-
dicating that a single defective gene is responsible for the
disease.6,7 Genetic heterogeneity has been demonstrated for
familial TAA, and 4 chromosomal loci have been mapped
for inherited forms of thoracic aortic disease: TAAD1 on
5q,8 TAAD2 on 3p,9 TAAD4 on 10q,10 the FAA1 locus on
11q,11 and a locus of 16p for TAA associated with patent
ductus arteriosus.12 The defective gene at the TAAD2 locus
was recently identified as TGFBR2. Mutations in TGFBR2,
TGFBR1, ACTA2, and MYH11 have been identified that
lead to varied phenotypes associated with TAAs and dissec-
tions.5,13,14 Similar to MFS, the aortas of patients with famil-
ial forms of TAA also demonstrate MD.
Previous studies have documented an inflammatory infil-
trate in the aortic wall of patients with TAA.15,16 In aortas of
patients undergoing prophylactic repair of TAAs, there were
significant increases in the number of CD31 and CD681
cells throughout the aortic media and adventitia when com-
pared with control aortas.15 Other investigators have alsoThe Journal of Thordocumented an inflammatory infiltrate in the aortic wall
that was associated with interferon-gamma production pro-
duction.16 In this study, we sought to further characterize
the inflammatory infiltrate in aortas of patients referred for
prophylactic repair of an ascending aortic aneurysm resulting
from single gene defects, such as MFS and familial TAA, and
sporadic, nonfamilial cases.
Materials and Methods
Subjects and Collection of Tissues
All patients gave signed consent to these studies, which were ap-
proved by the Institutional Review Board at the University of Texas
Health Science Center at Houston. Full aortic segments were col-
lected from patients undergoing elective repair of TAAs (N 5 20;
12 male and 8 female, mean age 46.9 6 16.6 years, range, 21–77
years) (Table 1). Five patients had MFS (3 male and 2 female,
mean age 35.6 6 11.2 years, range, 25–49 years), 6 unrelated pa-
tients had a family history of TAAs (4 male and 2 female, mean
age 44.86 18.1 years, range, 21–67 years), and 9 patients had spo-
radic TAA (5male and 4 female, mean age 54.66 15.4 years, range,
39–77 years). Control ascending aortas were obtained from 5 indi-
viduals at autopsy who died of a cause unrelated to aortic disease
and were not septic at the time of death (2 male and 3 female,
mean age 57.26 12.5 years, range, 44–74 years). Aortic specimens
were immediately transferred to the laboratory in a container with
cold Waymouth’s MB 752/1 Medium (Invitrogen Corp, Carlsbad,
Calif). Each specimen was divided into several parts for histochem-
istry, protein, and RNA extraction.
Immunohistochemistry Analysis of Aortic Tissue
The same antibodies were used for immunohistochemistry assay as
the previous study.15 The antibodies reacting to intercellular adhe-
sion molecule (ICAM)-1, vascular cell adhesion molecule
(VCAM)-1, and S-100 were obtained from Dako (Carpinteria, Ca-
lif), and the antibody to CD83 was obtained from Santa Cruz Bio-
technology (Santa Cruz, Calif). Immunohistochemistry assay
followed a standard protocol.15
T-cell Receptor b-Chain Variable Region Gene
Expression by Real-time Polymerase Chain Reaction
Analysis
Total RNA was extracted from aortic tissue and peripheral blood
mononuclear cells using the RNeasy Mini kit (Qiagen Valencia, Ca-
lif). cDNA was synthesized with Superscript II Reverse Transcrip-
tase (Invitrogen, Carlsbad, Calif). T-cell receptor b-chain variable
region (TCR BV) and TCR BJ gene expression was analyzed by
real-time quantitative polymerase chain reaction (PCR). Real-time
PCRwas performed in 96-well optical PCRplateswith SYBR-Green
PCRMasterMix (Applied Biosystems, Foster City, Calif) on anABI
7000 Sequence Detection System (Applied Biosystems) following
published protocols.17,18 Reactions were performed in duplicate.
Statistics Analysis
To test whether there were significant differences in the number of
positive inflammatory cell staining in the aortas between controls
and patients with MFS, familial thoracic aortic aneurysm (FTAA),
and TAA, exact Wilcoxon rank-sum tests were performed. Multipleacic and Cardiovascular Surgery c Volume 136, Number 4 923
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(significance levels were corrected for multiple comparisons by di-
viding them by the number of multiple comparisons). Linear regres-
sion analyses were conducted to investigate the association between
the number of positive cells and the age at surgery.
Results
Characterization of the Inflammatory Cells in
Thoracic Aortic Aneurysms of Patients with Marfan
Syndrome, Familial Thoracic Aortic Aneurysm, and
Sporadic Thoracic Aortic Aneurysm Referred for
Prophylactic Surgical Repair
Immunohistochemistry was performed using monoclonal an-
tibodies directed against markers for T and B lymphocytes
and macrophages to characterize the cells present in the aneu-
rysm wall in patients undergoing prophylactic repair of an
ascending aortic aneurysm. CD31 T cells were clearly ob-
served throughout the sections of aortic media and adventitia
of all patients with aneurysms but not in the control aortas
(Figure 1, CD3 staining), and confirmed by immunostaining
with a monoclonal antibody to CD45 (data not shown).
Further characterization indicated that CD41 and CD81 T
cells were both present in the aortas (Figure 1, CD4 and
CD8 staining). CD20 immunostaining detected a few B lym-
phocytes in the TAAs but no cells in control aortas (Figure 1,
CD20 staining). Staining with macrophage-specific antibody
indicated that all aneurysm tissue sections contained CD681
macrophages that were frequently present diffusely in the
TABLE 1. Clinical information of study participants
Sample ID TCRa
Age
correlationa Cell counta Cause Ethnicity Gender
Age at
surgery
Diameter
of aorta Smoking HTN BAV CD31 CD681
2664 Y Control C F 48 Normal NA NA N 0.9b 0.9b
2840 Y Y Control B F 74 Normal NA NA N 0.9 0.9
2613 Y Y Control B M 44 Normal NA NA N 1.4 0.9
2701 Y Y Control H F 54 Normal NA NA N 0.5 0.0
2976 Y Y Control H M 66 Normal NA NA N 3.2 0.9
2819 Y Y Y MFS H F 46 5.2 N Y N 52.7 23.2
3035 Y Y Y MFS H M 26 5.8 N N N 93.6 20.0
4520 Y Y Y MFS C M 25 5.2 N N N 51.8 23.6
4931 Y Y Y MFS B F 49 6.0 Y Y N 115.9 16.8
4958 Y Y Y MFS B M 32 6.0 Y Y N 58.6 26.4
846 Y Y Y FTAA C M 67 N/A Y Y N 61.8 13.6
4047 Y Y Y FTAA C M 56 5.7 N Y Y 35.0 18.2
5010 Y FTAA C F 55 6.7 N N N 56.8 35.2
2785 Y Y Y FTAA C M 21 4.5 Y N N 60.9 41.4
3400 Y Y Y FTAA C M 26 5.5 NA N NA 38.2 22.3
4477 Y Y FTAA C F 44 4.9 N N N 61.8 30.9
3943 Y Y Y TAA C M 42 6.3 N N N 42.3 9.1
4718 Y Y Y TAA C M 39 4.6 N Y Y 50.9 10.0
4488 Y Y Y TAA C M 52 4.7 N N N 22.7 9.1
4683 Y Y Y TAA C F 44 5.0 Y N Y 3.6 0
2478 Y Y TAA C F 74 5.9 Y Y N 7.7 6.8
2496 Y Y TAA C F 77 5.7 N Y N 4.5 6.4
2945 Y Y TAA C F 40 6.0 N Y N 53.6 9.5
2955 Y Y TAA C M 52 5.2 N Y N 29.5 7.3
3393 Y Y TAA C M 71 5.6 Y Y NA 20.5 6.8
MFS,Marfan syndrome; FTAA, familial thoracic aortic aneurysm; TAA, thoracic aortic aneurysm; HTN, hypertension; BAV, bicuspid aortic valve; NA, not avail-
able. aY5means that this samples has been used for the T-cell receptor assay, counting the number of various inflammatory cells present in the aortic media,
the correlation assay of the number of T lymphocytes and macrophages present in the aortic media, and the patient's age at the time of prophylactic repair.
bTotal cells per square millimeter.
Figure 1. Immunohistochemistry for markers of immune cells in the media and adventitia of aortas from controls and
patients with MFS, FTAA, and TAA. The marker recognized by the antibody used for immunohistochemistry, the seg-
ment of the aorta photographed, and the magnification are on the left. The cause of the aneurysm is on the top. The
orientation in the photographs is the lumen of the aorta at the bottom and the adventitia at the top. Color was de-
veloped with DAB for peroxidase (brown) or Fast Red for alkaline phosphatase (red). Magnification 2003 for panels
except CD3 adventitia staining. MFS, Marfan syndrome; FTAA, familial thoracic aortic aneurysm; TAA, thoracic
aortic aneurysm.924 The Journal of Thoracic and Cardiovascular Surgery c October 2008
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CDmedia and adventitia of the aortas from patients but were
rarely found in control aortas (Figure 1, CD68 staining).
Quantization of the positive immune cells in the aortic me-
dia indicated that the patients with MFS, FTAA, and TAA
had significantly increased amounts of CD31, CD41,
CD81, CD681, and CD201 cells when compared with con-
trol aortas (P , .01) (Figure 2). Furthermore, the number of
CD31 cells in aortas of patients with MFS and CD681 cells
in aortas of patients with MFS and FTAA were also signifi-
cantly increased when compared with those with sporadic an-
eurysms (P , .01). T cells were the predominant
inflammatory cell in the media, followed by macrophages.
However, there was no significant difference in degrees of
aortic enlargement among the 3 aneurysm groups (P 5
.661), suggesting that the increased numbers of immune cells
in the MFS and FTAA compared with sporadic TAA were
not due to aortic expansion.
These studies also revealed a large number of inflamma-
tory cells present in the adventitia, especially surrounding
the vasa vasorum (Figure 1, CD3 staining in adventitia). Al-
though both CD31 and CD681 cells were found in the ad-
ventitia, the cells surrounding the vasa vasorum were
predominantly CD31 (Figure 1, CD3, in adventitia). Infiltra-
tion of inflammatory cells in the adventitia was found to
a lesser degree in sporadic TAA aortas compared with those
of MFS and FTAA aortas, and not found in control aortas.
Immunohistochemistry performed using antibodies directed
against ICAM-1 and VCAM-1 showed that staining for
ICAM-1 and VCAM-1 was increased around the vasa vaso-
rum in the patients with FTAA and MFS compared with con-
trol aortas (Figure 3).
We sought to determine whether the number of inflamma-
tory cells present in the aortic media at the time of surgery
correlated with the patients’ age at the time of prophylactic
repair. These results demonstrated that both the number of
T lymphocytes and macrophages in the aortic media were
inversely related to the age of patients at the time of surgery
(r 5 20.71, P 5 .002; r 5 20.69, P 5 .002, respectively)
(Figure 4). In contrast, there was no correlation between the
diameter of the aortic aneurysm at the time of surgical repair
and the number of CD31 and CD681 cells (r 5 20.2045,
P 5 .447; r 5 20.1917, P 5 .477, respectively).
Characterization of T-cell Receptors in T
Lymphocytes in Aortic Media
To further characterize the genetic properties of the T cells in
the aortic wall, RNAwas extracted from the aortic tissues and
used to assess the T-cell receptors. Real-time quantitative
PCR assay for RNA expression demonstrated restricted use
of the TCR BV gene in T cells derived from diseased aortas.
A series of real-time PCR analyses revealed overexpression
of BV22 and BV25 in more than a majority of the aortic spec-
imens from patients with TAA (10/14 subjects) with 1 TCR
BV gene contributing to more than 20% of the total use926 The Journal of Thoracic and Cardiovascular Surgery c Oc(Figure E1). Overexpression of 1 gene was present in 5 sam-
ples for BV22 and 8 samples for BV25. The combination of
the expression level of BV22 and BV25 contributed to more
than 50% of the whole TCRBV gene use in 7 specimens. In
contrast, BV gene distribution appeared highly heteroge-
neous in the remainder of aneurysm aortas (3/14) and control
aortas. BV gene distribution also appeared highly heteroge-
neous in the paired peripheral blood mononuclear cells ob-
tained from patients with MFS and TAA.
Clonality of the overexpressed BV22 and BV25 of T cells
derived from selected aortic specimens by TCRBJ gene use
was also examined. The TCRBJ profile of BV22 and BV25
was analyzed by using BV22 or BV25 forward primers and
reverse primers for 13 BJ genes with real-time PCR. Both
BV22 and BV25 genes exhibited heterogeneous TCRBJ
gene profiles in aortic specimens derived from controls and
patients with TAA. These analyses revealed that no BJ genes
were preferentially used in the context of the overexpressed
BV22 and BV25 (data not shown).
The clonality of the T-cell receptors suggested that the T
lymphocytes may be replicating in response to specific anti-
gens presented by activated dendritic cells. Staining of the an-
eurysm aortas with a marker of activated dendritic cells,
CD83, showed rare CD831 cells located at the adventitial/
medial border, whereas CD831 cells were not found in con-
trol aortas (Figure 1, CD83).
Discussion
An inflammatory component in MD, composed primarily of
T cells and macrophages, was identified in TAAs resulting
from single gene disorders, MFS, and familial TAA, and non-
genetic, sporadic cases of TAA. More inflammatory cells
were present in the aortas of patients with single gene defects
than in patients with sporadic TAAs. The T-cell–associated
vasculitis of the vasa vasorum and the increased expression
of leukocyte adhesion molecules by the endothelial cells of
the vasa vasorum suggest that a pathway for T-cell migration
into the media is from the adventitia. The number of both in-
flammatory T lymphocytes and macrophages in the aortic
media negatively correlated with patients’ age at referral
for prophylactic surgical repair, thus raising the possibility
that the inflammatory infiltrate may contribute to disease pro-
gression. Alternatively, the inflammatory infiltrate could cor-
relate with the aortic dilatation and corresponding pathologic
changes, but not contribute to the disease progression. In con-
trast, there was no correlation between the size of the aorta
and the number of inflammatory cells, implying that the in-
flammatory infiltrate did not simply result from irritation of
the tissues from the progressive enlargement of the aorta. It
is interesting to note that recent studies have suggested that
dysregulation in TGF-b signaling contributes to aortic dis-
ease in both MFS and familial TAA caused by TGFBR2
mutations.19,20 TGF-b signaling plays a critical role in con-
trolling T-cell homeostasis and is required to preventtober 2008
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CDFigure 2. Morphometric quantization of lympho-
cytes, subpopulations of T cells, and macro-
phages in ascending aortas of controls and
patients with MFS, FTAA, and TAA. After immuno-
histochemistry of aortic tissue, CD3, CD4, CD8,
CD20, and CD68-positive cells in the media in 10
contiguous high-power fields (magnification
4003) were counted by 2 independent observers.
In the aortas of patients with MFS, FTAA, and TAA,
there was a significant increase in the number of
CD31, CD41, CD81, CD201, and CD681 cells
when compared with control aortas (*P < .01).
MFS, Marfan syndrome; FTAA, familial thoracic
aortic aneurysm; TAA, thoracic aortic aneurysm.undesirable self-targeted responses, suggesting that TGF-
b dysregulation may contribute to the aortic T-cell immune
response.21
Tang and colleagues16 also observed that leukocyte infil-
tration increased in the media of aortas with TAAs compared
with control aortas. They suggested dividing TAAs into 2
subgroups, bland and infiltrated aneurysms, on the basis of
whether leukocytes infiltrate into the inner half of aortic me-
dia. T and B lymphocytes were significantly increased in the
aortas with infiltrated aneurysms compared with those of
bland aneurysms and controls. Macrophages were signifi-
cantly increased in the aortic media with infiltrated aneu-
rysms compared with those of bland aneurysms and
controls. Although insufficient information is provided to de-
termine the clinical cause of infiltrated and bland TAAs, it
may be that the infiltrative aneurysms came from patients
with a genetic cause to their aneurysms and the bland aneu-
rysms were from patients with sporadic TAAs.
There are similarities between the characteristics of the in-
flammatory infiltrate present in TAAs and the inflammatory
infiltrate described in giant-cell arteritis and Takayasu’s arter-
itis. These disorders demonstrate a similar cellular immuneThe Journal of Thorresponse involving T cells, primarily CD41 cells and macro-
phages, without evidence of an autoantibody component con-
tributing to the pathology.22 Histology studies indicate that T
cells enter tissue with activation of endothelial cells in the
vasa vasorum and not through the intimal endothelium. Fur-
thermore, a limited T-cell receptor repertoire has been shown
to infiltrate the aortic tissue in Takayasu’s arteritis, suggest-
ing that an aortic tissue antigen presented in the cleft of cer-
tain major histocompatibility complex molecules in the aortic
tissue was targeted by the T cells.23 Restricted use of T-cell
receptors on the T cells was also identified in TAAs, specif-
ically TCRBV18, TCRBV22, and TCRBV25. Although the
direct link between dendritic cell function and T-cell activa-
tion remains unclear in the TAA tissue, the presence of acti-
vated dendritic cells capable of presenting antigen in the
adventitia of TAAs but not in the control aortas provides fur-
ther support that a tissue antigen is targeted by the T cells.
Once activated, CD41 T cells can polarize into T-helper
type I (Th1) or 2 (Th2) cells, which in turn control the inflam-
matory cascades in different diseases. A recent study of trans-
mural inflammation of TAAs indicated that the Th1-type or
proinflammatory process is the dominant immune responseFigure 3. Increased expression of leukocyte ad-
hesion molecules, ICAM-1, and VCAM-1 in the
vasa vasorum in the adventitia of patients with
MFS and FTAA. Immunohistochemistry revealed
positive immunostaining for ICAM-1 and VCAM-
1 in the vasa vasorum from patients with MFS
and FTAA. Magnification 4003.MFS,Marfan syn-
drome; FTAA, familial thoracic aortic aneurysm;
ICAM, intercellular adhesion molecule; VCAM,
vascular cell adhesion molecule.acic and Cardiovascular Surgery c Volume 136, Number 4 927
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CDFigure 4. Inverse correlation between the age of
patients at the time of prophylactic repair of the
aorta and the number of T lymphocytes (CD31
staining) and macrophages (CD681 staining) in
the aortic media of patients. CD31 cells (A) and
CD681 cells (B) were counted in 10 contiguous
high-power fields of the aortic media of TAAs
from 19 patients with MFS, FTAA, and sporadic
TAA.occurring in aneurysms. The up-regulation of interferon-
gamma significantly correlated with both outward vascular
remodeling and intimal expansion of TAAs.16 Th1 responses
favor effective clearance of intracellular pathogens and play
crucial roles in the pathophysiology of organ-specific auto-
immune diseases. Autoimmune encephalomyelitis24 and thy-
roiditis25 are two good examples that autoimmune diseases
are initiated by Th1-mediated responses. The prominent au-
toimmune cause of multiple sclerosis is also considered to
be the aberrant activation of interferon-gamma–producing
Th1 cells that recognize self-peptides of the myelin sheath.
The restricted uses of TCRBV and infiltration of predominant
Th1-type cells in TAA lesions suggest that a Th1-mediated
proinflammatory response could be a mechanism that con-
tributes to the pathogenesis of TAA.
The results of our study parallel the results of a novel
mouse model of TAAs, the interleukin-1 receptor antagonist
deficient mouse (interleukin-1-Ra-/-).26 An inflammatory
aortitis of the ascending aorta develops in the deficient
mice that is not present in wild-type mice, involving the me-
dial infiltration of T lymphocytes and macrophages. Further-
more, peripheral T cells from the interleukin-1-Ra-/- mouse
cause aortic aneurysms in nu/nu mice, suggesting that acti-
vated or memory T cells are generated and involved in the de-
velopment of the ascending aortic disease. As in giant cell
and Takayasu’s arteritis, the pathogenic antigens in the aorta
in this mouse model require further investigation.
In our study, no preferential use of BJ gene was selected in
the context of overexpressed BV22 and BV25 in the majority
of TAA aortas, leading to an alternative possibility that
a superantigen-driven stimulation of Vb22 and Vb25-posi-
tive T cells in the aortic tissues of patients with TAA may
be one of the major mechanisms contributing to the initial im-
mune response in the aortic tissue. Mitogens, superantigens,
and nominal antigens use distinct mechanisms to activate T
cells and induce proliferation. Mitogens and nominal anti-
gens induce a polyclonal proliferation of T cells indepen-
dently of the TCRBV family expressed. In contrast,
stimulation of certain superantigens, such as toxic shock syn-
drome toxin-1, is based on the TCR BV family and indepen-
dent of complementary determining region 3 sequence. The928 The Journal of Thoracic and Cardiovascular Surgery c OctoT-cell response to superantigens is oligoclonal and restricted
in terms of complementary determining region 3.
The phenotype and biological activity of invading T cells
and macrophages in TAAs should be further characterized
before drawing conclusions on their relevance to the disease
process. The limited access to aortic tissue in humans im-
pedes assessing the role of the inflammatory infiltrate in dis-
ease progression. Despite these limitations, our study results
suggest that an immune-mediated aortitis may contribute to
the pathogenesis of TAAs and that a spectrum of aortic dis-
ease processes from Takayasu’s arteritis to TAA formation
involve inflammatory infiltrates in the aortic media. Further
investigations are needed to verify the role of this inflamma-
tory infiltrate in the progressive molecular pathology of
TAAs.
The authors are grateful to the patient and their physicians
involved in this study and to Dr Craig T. Bason for referring a patient
for this study.
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CDFigure E1. TCR BV gene distribution profiles in the aortas of controls and patients with MFS, FTAA, TAA, and spo-
radic TAA, and in peripheral blood mononuclear cells of patients with MFS and TAA. TCR BV gene expression was
analyzed quantitatively using RNA from aortic tissue and peripheral blood mononuclear cells by real-time PCR using
specific primers for 25 BV genes. BV gene distribution is presented as the mean percentage expression of each BV
gene relative to BC expression on the y axis.MFS,Marfan syndrome; FTAA, familial thoracic aortic aneurysm; TAA,
thoracic aortic aneurysm; CTL, control; PBMC, peripheral blood mononuclear cell.929.e1 The Journal of Thoracic and Cardiovascular Surgery c October 2008
